文献速递皮肤肿瘤

三维全身皮肤成像用于黑色素瘤自动检测

3D Whole-body skin imaging for automated melanoma detection.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-03-24

单中心回顾性观察性便利样本研究,纳入35例在三级癌症医院确诊的黑色素瘤患者,分析诊断性皮肤活检前90天内采集的全身3D图像。自动分析识别出23,538个直径>2 mm的皮肤病变,其中黑色素瘤49个、非黑色素瘤22,489个,预测模型AUC为0.94(95%CI:0.92-0.96)。

要点

  • 自动分析全身3D图像可区分黑色素瘤与其他皮肤病变,AUC为0.94(95%CI:0.92-0.96)。
  • 患者层面分析中,14个(28%)黑色素瘤病变获得最高预测评分或位于该患者全部病变的第99百分位。
  • 作者认为需更大规模、更高质量、更具代表性的3D成像数据集来改进和验证结果。

核心结论

  • 在这项概念验证性先导研究中,使用简单图像处理技术对全身3D图像进行自动分析,能以高准确度区分黑色素瘤与其他皮肤病变。
  • 作者指出需要更大规模、更高质量、更具代表性的3D成像数据集来改进和验证这些结果。

研究设计与样本

  • 单中心、回顾性、观察性便利样本研究,纳入在三级癌症医院确诊为黑色素瘤的患者。
  • 纳入条件为在诊断性皮肤活检前90天内采集过全身3D图像。
  • 3D图像按标准诊疗使用VECTRA WB360全身三维成像系统(Canfield Scientific)获取。
  • 从VECTRA DermaGraphix研究软件导出所有合格参与者的图像处理自动数据(即病变大小、颜色、边界)用于分析。
  • 主要结局为受试者工作特征曲线下面积(AUC)。

主要发现

  • 共35例患者贡献了23,538个自动识别的最大直径>2 mm的皮肤病变(每位参与者102-3021个病变)。
  • 所有患者均为白人,23例(66%)为男性,中位(范围)年龄为64岁(26-89)。
  • 共有49个黑色素瘤病变和22,489个非黑色素瘤病变。
  • 预测模型的AUC为0.94(95%CI:0.92-0.96)。
  • 在患者层面分析中考虑所有病变时,14个(28%)黑色素瘤病变获得最高预测评分或位于该个体患者全部病变的第99百分位。

局限性

  • 原文为单中心、回顾性、观察性便利样本研究。
  • 原文样本量为35例患者,作者在结论中称其为概念验证性先导研究。
  • 作者指出需要更大规模、更高质量、更具代表性的3D成像数据集来改进和验证这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Existing artificial intelligence for melanoma detection has relied on analysing images of lesions of clinical interest, which may lead to missed melanomas. Tools analysing the entire skin surface are lacking. OBJECTIVES: To determine if melanoma can be distinguished from other skin lesions using data from automated analysis of 3D-images. METHODS: Single-centre, retrospective, observational convenience sample of patients diagnosed with melanoma at a tertiary care cancer hospital. Eligible participants were those with a whole-body 3D-image captured within 90 days prior to the diagnostic skin biopsy. 3D-images were obtained as standard of care using VECTRA WB360 Whole Body 3-dimensional Imaging System (Canfield Scientific). Automated data from image processing (i.e. lesion size, colour, border) for all eligible participants were exported from VECTRA DermaGraphix research software for analysis. The main outcome was the area under the receiver operating characteristic curve (AUC). RESULTS: A total of 35 patients contributed 23,538 automatically identified skin lesions >2 mm in largest diameter (102-3021 lesions per participant). All were White patients and 23 (66%) were males. The median (range) age was 64 years (26-89). There were 49 lesions of melanoma and 22,489 lesions that were not melanoma. The AUC for the prediction model was 0.94 (95% CI: 0.92-0.96). Considering all lesions in a patient-level analysis, 14 (28%) melanoma lesions had the highest predicted score or were in the 99th percentile among all lesions for an individual patient. CONCLUSIONS: In this proof-of-concept pilot study, we demonstrated that automated analysis of whole-body 3D-images using simple image processing techniques can discriminate melanoma from other skin lesions with high accuracy. Further studies with larger, higher quality, and more representative 3D-imaging datasets would be needed to improve and validate these results.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Marchetti MA, Nazir ZH, Nanda JK, et al. 3D Whole-body skin imaging for automated melanoma detection. J Eur Acad Dermatol Venereol. 2023. PMID: 36708077. doi:10.1111/jdv.18924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。